These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4236695)

  • 21. USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY.
    RITZ ND; RUBIN H
    J Lab Clin Med; 1964 Feb; 63():344-54. PubMed ID: 14125123
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 23. A simple method for purification of bovine plasminogen.
    Nagasawa S; Suzuki T
    J Biochem; 1969 Aug; 66(2):273-5. PubMed ID: 4242209
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of fibrinolysis. A comparative thrombelastographic study.
    Egeblad K
    Scand J Clin Lab Invest Suppl; 1967; 98():1-69. PubMed ID: 4228724
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolytic and plasminogen activator activity in proteinase fractions from swine leucocytes.
    Stegnar M; Kopitar M; Accetto B; Lebez D
    Acta Med Iugosl; 1973; 27(5):435-47. PubMed ID: 4773098
    [No Abstract]   [Full Text] [Related]  

  • 26. [The fibrin agar plate method (author's transl)].
    Fujita S
    Rinsho Byori; 1976 Apr; 24(4):312-5. PubMed ID: 132549
    [No Abstract]   [Full Text] [Related]  

  • 27. The fibrinolytic enzyme system of human blood plasma in pregnancy.
    Lauritsen OS
    Scand J Clin Lab Invest; 1969 May; 23(3):191-6. PubMed ID: 4245823
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 29. [Plasminogen and plasmin determination in human plasma].
    Bruhn HD; Müller L; Duckert F
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1650. PubMed ID: 4235242
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 31. [Euglobulin lysis time method (author's transl)].
    Kazama M
    Rinsho Byori; 1976 Apr; 24(4):316-20. PubMed ID: 132550
    [No Abstract]   [Full Text] [Related]  

  • 32. Methods for studying fibrinolytic pathway components in human plasma.
    Wohl RC; Sinio L; Robbins KC
    Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The fibrinolytic system. Endogenous and exogenous activation in the drug treatment of thrombosis].
    Meneghini P; Giuron G; Gallo L; Lo Pinto G; Claudiani F
    Recenti Prog Med; 1982 Jun; 72(6):770-800. PubMed ID: 6216564
    [No Abstract]   [Full Text] [Related]  

  • 34. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 35. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of fibrinolytic enzymes from human cornea.
    Pandolfi M; Astedt B; Dyster-Aas K
    Acta Ophthalmol (Copenh); 1972; 50(2):199-205. PubMed ID: 4261829
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fibrinolytic activity in the blood of the paralyzed upper extremity].
    Blatný J; Urbánek K; Fischerová E
    Blut; 1970 Aug; 21(2):87-90. PubMed ID: 4251404
    [No Abstract]   [Full Text] [Related]  

  • 38. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
    Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW
    Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441
    [No Abstract]   [Full Text] [Related]  

  • 39. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spectrophotometric determination of the plasmin inhibition capacity of human serum].
    Duck HJ; Wagner J
    Dtsch Gesundheitsw; 1971 Oct; 26(41):1928-31. PubMed ID: 4258754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.